Virtual pharmaceutical R&D: a strategy for the millennium?

被引：8
|
作者：
Love, B [1 ]
机构：
[1] Destiny Pharma, Sussex Innovat Ctr, Brighton BN1 9SB, E Sussex, England
来源：
PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY | 1998年 / 1卷 / 03期
关键词：
D O I：
10.1016/S1461-5347(98)00026-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
[No abstract available]
引用
收藏
页码：89 / 90
页数：2
相关论文
共 50 条
  • [21] R&D portfolios and pharmaceutical licensing
    Nishimura, Junichi
    Okada, Yosuke
    [J]. RESEARCH POLICY, 2014, 43 (07) : 1250 - 1263
  • [22] R&D EFFECTIVENESS IN THE PHARMACEUTICAL INDUSTRY
    Konopielko, Lukasz
    Trehubova, Anastasiia
    [J]. ECONOMIC AND SOCIAL DEVELOPMENT (ESD 2018): 33RD INTERNATIONAL SCIENTIFIC CONFERENCE ON ECONOMIC AND SOCIAL DEVELOPMENT "MANAGERIAL ISSUES IN MODERN BUSINESS", 2018, : 287 - 296
  • [23] The productivity crisis in pharmaceutical R&D
    Fabio Pammolli
    Laura Magazzini
    Massimo Riccaboni
    [J]. Nature Reviews Drug Discovery, 2011, 10 : 428 - 438
  • [24] Will genomics revolutionise pharmaceutical R&D?
    Noble, D
    [J]. TRENDS IN BIOTECHNOLOGY, 2003, 21 (08) : 333 - 337
  • [25] Pharmaceutical R&D and the chemical engineer
    Stracey, J
    [J]. TCE, 2002, (732): : 36 - 37
  • [26] Applications of lipidomics in pharmaceutical R&D
    Ekroos, Kim
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 34 (01) : S22 - S23
  • [27] Pharmaceutical R&D: an age of change?
    Baldwin, John J.
    [J]. FUTURE MEDICINAL CHEMISTRY, 2014, 6 (10) : 1109 - 1112
  • [28] MANAGING RISK IN PHARMACEUTICAL R&D
    Case, Randolph H.
    [J]. RESEARCH-TECHNOLOGY MANAGEMENT, 2010, 53 (02) : 24 - 32
  • [29] R&D in the Global Pharmaceutical Markets
    Kermani, Faiz
    Wollowitz, Susan
    [J]. FUTURE OF THE CHEMICAL INDUSTRY, 2009, 1026 : 19 - 45
  • [30] The changing shape of pharmaceutical R&D
    Nicolaides, D
    [J]. CHEMICAL INNOVATION, 2001, 31 (11): : 40 - 46
12345